The role of interleukin-24 in atopic dermatitis
Atopic dermatitis (AD) is characterized by skin barrier disruption, type 2 immune dysregulation, chronic pruritus, and abnormal colonization by Staphylococcus aureus (S. aureus). Tapinarof, an aryl hydrocarbon receptor modulator, has been demonstrated to attenuate the development of AD in clinical s...
Guardado en:
Autores principales: | Yen Hai Vu, Masutaka Furue, Gaku Tsuji |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Open Exploration Publishing Inc.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/856e2ee9c914464eabc7d770cfa8b188 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and Upadacitinib
por: Miguel Nogueira, et al.
Publicado: (2021) -
The New Era of Biologics in Atopic Dermatitis: A Review
por: Simon Schneider, et al.
Publicado: (2021) -
Dupilumab side effect in a patient with atopic dermatitis: a case report study
por: Albader SS, et al.
Publicado: (2019) -
Interleukin-22 and keratinocytes; pathogenic implications in skin inflammation
por: Masutaka Furue, et al.
Publicado: (2021) -
Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study
por: Takeshi Nakahara, et al.
Publicado: (2021)